Sissetulev kiriAvalik
Esindajate nimetamine
Sotsiaalministeerium · 12. november 2018
- Viit
- 1.4-2/3490-1
- Registreeritud
- 12. november 2018
- Dokumendi liik
- Sissetulev kiri
- Adressaat
- EV alaline esindus EL juures
- Saabumis/saatmisviis
- e-post
- Funktsioon
- 1.4 EL otsustusprotsess ja rahvusvaheline koostöö
- Sari
- 1.4-2 Rahvusvahelise koostöö korraldamisega seotud kirjavahetus (Arhiiviväärtuslik)
- Toimik
- 1.4-2/2018
- Vastutaja
- Eda Lopato (Sotsiaalministeerium, Kantsleri vastutusvaldkond, Terviseala asekantsleri vastutusvaldkond, Ravimiosakond)
- Lahendamise tähtaeg
- 12. detsember 2018
Sisu (failidest)
Tere
Edastan Euroopa Ravimiameti kirja.
Reg. number: 14-4/1763
Reg. kuupäev: 09.11.2018
Sisu: Nomination of representatives in the Management Board (MB) of the European Medicines
Agency
Heade soovidega
Tiiu Noobel
sekretär EV AEEL juures
Saatja: Albuquerque Sophia <[email protected]>
Saaja: Esindus EL juures üldaadress, [email protected]
Teema: Estonia_2018.11.08_Nomination invitation for MB representatives
Your Excellency,
I am pleased to attach herewith a copy of the European Medicines Agency's invitation to nominate representatives to the Agency's Management Board.
A copy of this correspondence has been sent to the head of the relevant competent authority in your country.
Yours faithfully,
Sophia Albuquerque
Management Board & HMA
Office of the Deputy Executive Director
European Medicines Agency
30 Churchill Place | Canary Wharf | London E14 5EU | United Kingdom
Tel. +44 (0)20 3660 6918
[email protected]<mailto:[email protected]> | www.ema.europa.eu<http://www.ema.europa.eu/>
This message and any attachment contain information which may be confidential or otherwise protected from disclosure. It is intended for the addressee(s) only and should not be relied upon as legal advice unless it is otherwise stated. If you are not the intended recipient(s) (or authorised by an addressee who received this message), access to this e-mail, or any disclosure or copying of its contents, or any action taken (or not taken) in reliance on it is unauthorised and may be unlawful. If you have received this e-mail in error, please inform the sender immediately.
________________________________________________________________________
This e-mail has been scanned for all known viruses by European Medicines Agency.
________________________________________________________________________